FDA Approves Over-the-Counter Glucose Monitoring System for Weight Management
The FDA has approved the Signos Glucose Monitoring System for over-the-counter use, helping individuals manage weight and improve metabolic health through personalized, AI-driven insights.
The U.S. Food and Drug Administration (FDA) has officially approved the Signos Glucose Monitoring System for over-the-counter use, specifically designed to aid in weight management. This innovative system combines the Dexcom Stelo biosensor with an AI-powered platform that provides real-time insights into how food intake, physical activity, stress, sleep, and timing influence glucose levels. By integrating advanced technology with personalized health guidance, Signos aims to empower individuals to make informed decisions about their lifestyle and health.
One of the standout features of this device is its ability to translate fluctuations in glucose into simple, actionable recommendations. It uses the body's own signals, analyzed through artificial intelligence, to guide users in optimizing sleep, managing weight, and reducing the risk of chronic diseases. The system also tracks responses to meals, exercise, sleep, and stress, connecting these factors to glucose levels to foster better health habits.
Users can subscribe to Signos through plans costing $139 per month for three months or $129 per month for six months, with the company providing all necessary continuous glucose monitors during the subscription period. This development comes at a critical time, as data shows that nearly 74% of U.S. adults are classified as overweight or obese, and projections indicate that diabetes diagnoses could reach 1.3 billion globally by 2050. The rapid escalation of metabolic health issues underscores the importance of accessible, technology-driven management tools.
Sharam Fouladgar-Mercer, CEO and founder of Signos, remarked that this initiative goes beyond launching a product—it's about transforming how people see and manage their health. He emphasizes that everyone should have access to personalized insights that promote healthier, longer lives. Signos' approach focuses on giving individuals control over their health journeys through data and technology, creating a new standard in metabolic health support.
For more details, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Preventing Postoperative Delirium: Low-Cost Strategies to Protect Brain Health
New research reveals that postoperative delirium, a common complication in older surgical patients, is preventable through simple, low-cost interventions that can improve outcomes and reduce healthcare costs.
The Critical Role of Educating Children About Zoonotic Diseases and Safe Animal Interactions
Learn about the importance of teaching children safe interactions with animals to prevent zoonotic diseases and protect their health.
Innovative Cell Replacement Technique Slows Neurodegeneration in Mice: Potential Breakthrough for Alzheimer's and Similar Diseases
Stanford Medicine researchers have developed a breakthrough technique in mice to replace brain immune cells, microglia, leading to slowed neurodegeneration. This innovative cell therapy offers hope for treating devastating diseases like Alzheimer's and lysosomal storage disorders.
FDA Approves New Sublingual Nonopioid Treatment for Fibromyalgia
The FDA has approved Tonmya, a novel sublingual, nonopioid medication, for adults with fibromyalgia, marking a significant advancement in pain management options for this chronic condition.